"The company has a strong track record and management team, as well as a brownfields development pipeline to unlock future growth," she said.
Chief executive Earl Gasparich said the book build had been oversubscribed with strong demand from New Zealand, Australian and international investors.
"Price and volume leadership were considered in the allocation process, enabling Oceania to establish a high quality register of domestic and international investors," Gasparich said.
The shares were allocated to institutional investors in New Zealand, Australia, and certain other international jurisdictions, to brokers on behalf of private clients in New Zealand, and to selected persons who participated in a priority offer.
Upon listing, Oceania will join Ryman Healthcare, Summerset and Metlifecare which are also listed on the NZX.
The indicative rang for the offer was 76c to $1.04.